Tetra Bio-Pharma Inc (TSX:TBP) (OTCQB:TBPMF) (FRA:JAM1) COO Steve Neron tells Proactive it has signed a letter of intent with Danish company DanCann Pharma for the exclusive distribution of its Reduvo Adversa and QIXLEEF products in Denmark, Norway, Sweden, Finland, and Germany. Neron says subject to registration with the European Medicines Agency, DanCann will handle the exclusive sales and distribution in the Nordics and Germany for Reduvo Adversa and QIXLEEF, a botanical cannabinoid-derived medicine, as well the over-the-counter (OTC) medicinal cannabis product ENJOUCA.
Tetra Bio Pharma signs LOI to sell its pain management products with Danish distribution company
